Viral Vectors

CUSTOMER CHALLENGE

Viral vectors can be used for a range of applications, from direct in vivo gene delivery in genetic therapies, to in vitro transduction for gene modified cell therapies such as CAR-T, as well as oncolytic applications. Manufacturing the virus is almost always highly complex, involving critical input materials such as plasmids, meaning there are much higher production costs than traditional biopharmaceuticals.

Traditional testing approaches often do not provide the requisite detail of information that the regulators require. Combined with widespread compatibility and volume requirement issues, customers must find alternative testing and release strategies for these incredible new modalities.

PATHOQUEST SOLUTION

PathoQuest can help characterize, QC and release your viral vectors across the manufacturing journey

DISCOVERY

PRE-CLINICAL

PHASE 1

PHASE 2

PHASE 3

MARKET

Cell line selection

Viral seed selection

Cell line characterization – MCB, WCB, End of Production

Viral seed stock characterization

In-process testing – bulk harvest lot release, biosafety and viral testing

Final product release testing

Monitoring – on/off target integration, replication competency

Plasmid identity testing and raw material screening

Investigatory support

PATHOQUEST SOLUTION

PathoQuest can help characterize, QC and release your viral vectors across the manufacturing journey

OUR EXPERTISE

PathoQuest has been working with many leading global innovators to help them address the unique challenges that viral vectors present. By using our expert GMP NGS services, our clients have been able to overcome compatibility issues with traditional cell or animal-based testing and characterization, enabling them to deliver life-changing therapies to patients. 

PathoQuest actively participates in regulatory and expert industry interest groups, associations and consortia, as well as frequently publishing in peer-reviewed journals. We lead the way in both innovation and acceptance of NGS technology, especially when applied to the specific challenges of viral vector QC.

CHALLENGES SOLVED

PathoQuest addresses the key challenges you face in manufacturing and releasing your viral vector by addressing key concerns:

  • Faster cell line development and clone selection with deeper genetic insights
  • De-risking your manufacturing process by rapidly screening critical raw materials such as serum and plasmids
  • Reducing the cell line and plasmid characterization bottleneck, allowing you to get your therapy into clinic faster
  • Detection of sequence variation to low levels, ensuring the highest possible quality and safety
  • Addressing key concerns with viral vector testing by reducing volume requirements and cell-based assay compatibility issues
  • Providing additional assurance of biosafety where processes such as viral clearance can be challenging
  • Meeting corporate 3Rs ethical objectives by removing animal models

Modalities

mAbs and Recombinants

Bacterial and mammalian produced proteins, hormones and peptides

READ MORE

Viral Vectors

Viral gene delivery, oncolytic and immunotherapy including manufacturing plasmids

READ MORE

Cell Therapies

Including gene modified, or unmodified stem cell therapies, allogeneic or autologous

READ MORE

Vaccines

Inactivated, live-attenuated, recombinant, RNA and viral vector products

READ MORE

RNA

Immunotherapies, antiviral, vaccines, RNAi and CRISPR based gene editing

READ MORE

Cultivated Meat

Engineered cells and tissues cultured in more ethical in vitro environments

READ MORE

Contact us

U.S.

+1 484 212 9360

466 Devon Park Dr
Wayne, PA 19087
United States

Sign up for our latest news

France

+33 (0)1 70 82 17 90

Biopark -Bâtiment B,
11, rue Watt
75013 Paris, France

How can PathoQuest help?

Name(Required)
This field is for validation purposes and should be left unchanged.

U.S.

+1 484 212 9360

466 Devon Park Dr
Wayne, PA 19087
United States

France

+33 (0)1 70 82 17 90

Biopark -Bâtiment B,
11, rue Watt
75013 Paris, France

How can PathoQuest help?

Name(Required)
This field is for validation purposes and should be left unchanged.

Sign up for our latest news